Comparative Effectiveness Reaches Into Drug Reviews, FDA Documents Show
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
As the health care reform debate focuses on the appropriate role of comparative effectiveness research, a look at FDA’s review practices gives some insight into how the agency already takes the concept into account in its review decisions.